Endo Launches Bivalirudin Injection in Ready-to-Use Vials

Only ready-to-use liquid format of bivalirudin on the market Does not require reconstitution, dilution or mixing, which helps increase efficiency for hospitals and healthcare providers DUBLIN, July 18, 2023 /PRNewswire/ — Endo International plc (OTC: ENDPQ) announced today that its Par…